Account
ISPOR Europe 2024
News

ISPOR Europe 2024

29/08/2024

We’re delighted to announce our participation at ISPOR Europe 2024, taking place in Barcelona this November. Below, you can learn more about our team members who will be attending, discover our booth’s location in the exhibition hall, book a meeting with us, and get a glimpse of the research we’re proud to present at the event.

Our daily summaries and post-conference reports will be accessible via the link at the bottom of this page. Stay tuned for more updates!


This year’s theme: “Generating Evidence Toward Health and Well-Being”

ISPOR brings together global experts in health economics and outcomes research (HEOR) to discuss the pivotal role of scientific evidence in improving the health and well-being of populations worldwide. The conference will feature a diverse programme that explores the science, practice, and policies of healthcare value assessment, with a focus on a holistic approach that considers the physical, mental, and social dimensions of health. Attendees will have the opportunity to engage in discussions on key topics such as joint clinical assessments, the use of real-world data, the evolving definition of healthcare value, patient-centred research, the digital transformation of health, and recent developments in European regulatory and policy frameworks.


Say hello

Remap Consulting will have an Exhibition Booth (Booth 1113) in the main exhibition hall at the conference, where you’ll always be able to find one of team and learn more about how we can help you solve your pricing and market access challenges to enable improved patient access. Please come along and say hi!


Our team

We’re pleased to present our conference team this year, with expertise spanning a wide range of areas, including health economics, RWE, market access, and HTA.

If you’d like to arrange a meeting with any of our attendees at the conference then please contact us here.


Our research posters

We’re delighted to announce that our team will be showcasing eight distinct research topics at ISPOR Europe. We’re looking forward to engaging with you and discussing our research during the poster sessions and tours. For a more in-depth look, please click on the titles below to access the abstracts.

DateResearchResearch IDSessionSession TimeDiscussion PeriodPresented By
18th NovemberAre Companies Ready for the New EU HTA, or Is It an Impossible Task?HTA33110:30 AM – 1:30 PM12:30 PM – 1:30 PMGraham Foxon
18th NovemberImplications of Indication Expansions on Pricing and Reimbursement and Differences Between EU4 and UK MarketsHTA13424:00 PM – 7:00 PM6:00 PM – 7:00 PMPaul Craddy
19th NovemberHow Could ATMPs Demonstrate an Economic Benefit for Payers and What Are the Real-World Examples of This?EE420310:30 AM – 1:30 PM12:30 PM – 1:30 PMPaul Craddy
19th NovemberProactive Risk Surveillance for Heart Failure and Stroke: A Quality-by-Design Approach with Multimodal Data IntegrationRWD104310:30 AM – 1:30 PM12:30 PM – 1:30 PMMariam Bibi
19th NovemberAlignment of EU HTA and Member State Clinical Assessments and the Potential Impact on Value PerceptionHTA189310:30 AM – 1:30 PM12:30 PM – 1:30 PMLauren Boland
19th NovemberLeveraging Real-World Data for Enhanced Clinical Decision Support Systems: A Data-Driven ApproachRWD14444:00 PM – 7:00 PM6:00 PM – 7:00 PMKavitha Baruah
19th NovemberCan Patient Involvement Help Optimise Patient Outcomes and Healthcare Decision-Making?PCR20944:00 PM – 7:00 PM6:00 PM – 7:00 PMDevan Hopkinson
19th NovemberEvaluating the Capabilities of AI Tools for Extracting Pricing and Reimbursement InsightsMSR14744:00 PM – 7:00 PM6:00 PM – 7:00 PMLauren Boland

Insights

Just like in past years, Remap Consulting will be crafting daily summaries of the essential conference topics, including the plenary sessions. Have you subscribed to our newsletter yet? Subscribers are the first to receive these summaries! Don’t miss out on the latest insights.


ISPOR Eu 2024 Summary – Day 1

ISPOR Eu 2024 Summary – Day 2

ISPOR Eu 2024 Summary – Day 3

Stay in the know, subscribe to our newsletter

Be the first to receive exclusive content on the latest from the pharmaceutical and market access sector.